Biotech startups in MENA
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Remepy | Ramat Gan | Series A | $36.0M | 2026-08-12 |
| Phytolon | Yoqne`am `illit | Series B | $23.6M | 2026-05-26 |
| Scala Biodesign | Tel Aviv | Series A | $16.0M | 2026-03-31 |
| MDClone | Be'er Sheva | Series C | $63.0M | 2022-03-01 |
| CytoReason | Tel Aviv | Series B | $80.0M | 2024-07-17 |
| Imagene AI | Tel Aviv | Series B | $23.0M | 2025-07-01 |
| M-Based | Ankara | Seed | $700K | 2026-10-01 |
| Accellix | Jerusalem | Series E | $10.0M | 2021-12-13 |
8 rows of the CSV in 5 of its 18 columns.
- The 266 biotech startups in MENA have raised $1.9B in total.
- 18 of them closed their most recent round in the last 12 months, $148.0M combined.
- The largest of those rounds is Remepy's $36.0M Series A, dated August 2026.
- The most recent is Undecimal Bio's $18.0M seed round on 12 October 2026.
- Turkey Development Fund is an investor in 12 of them, more than any other fund.
- Health care is the most common other sector, with 182 companies (68%).
- 34% were founded in 2020 or later; the median founding year is 2017.
- The most common team size is 1 to 10 employees (53% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
26 of 266| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| M-Based | M-Based develops eco-friendly alternative materials made from mycelium, the root structure of mushrooms. | Biotech | Ankara, Turkey | Seed | $700K | 2026-10-01 | $700K | Hatcher+, Sente Ventures, Fark Labs | 1 to 10 | |
| Remepy | Remepy develops hybrid drugs that combine multiple therapeutic approaches for biotechnology research. | Artificial intelligence | Ramat Gan, Israel | Series A | $36.0M | 2026-08-12 | $51.0M | Samsung NEXT, NFX, Vine Ventures +2 | 11 to 50 | 2022 |
| Phytolon | Phytolon supplies natural food colors of high quality at low cost. | Biotech | Yoqne`am `illit, Israel | Series B | $23.6M | 2026-05-26 | $43.7M | MassChallenge, Trendlines Group, Millenium Food-Tech | 11 to 50 | 2018 |
| Viseur AI | Viseur AI provides a medical imaging platform that helps hospitals and labs deploy digital pathology and radiology workflows. | Artificial intelligence | Ankara, Turkey | Seed | $350K | 2026-05-20 | $897K | Turkey Development Fund | 11 to 50 | 2024 |
| Scala Biodesign | Scala Biodesign provides partners with a computational solution that increases the value of proteins and speeds their development. | Artificial intelligence | Tel Aviv, Israel | Series A | $16.0M | 2026-03-31 | $26.2M | Intel Capital, Intel Ignite, TLV Partners | 1 to 10 | 2022 |
| Kybele's Garden | Kybele's Garden grows algae using bioponics and algae fermentation methods. | Biotech | Çankaya, Turkey | Seed | $420K | 2025-09-08 | $670K | Hatcher+, Sente Ventures | 1 to 10 | 2021 |
| Nutriente Life Food Biotechnology Chemistry | Nutriente Life Food Biotechnology Chemistry develops food biotechnology products that support healthy living. | Biotech | Sariyer, Turkey | Pre-seed | $27K | 2024-09-04 | Turkey Development Fund | 1 to 10 | 2024 | |
| Cellestetix | Cellestetix develops plant-based exosome formulas for skin, hair, and wellness regeneration. | Biotech | Istanbul, Turkey | Seed | $2.0M | 2024-08-16 | APY Ventures, Maxis, Arya Ventures +2 | 2020 | ||
| CytoReason | CytoReason develops a cell-centered computational model of the human body to find patterns in biological data. | Artificial intelligence | Tel Aviv, Israel | Series B | $80.0M | 2024-07-17 | $100.0M | OurCrowd, Asymmetry Ventures, Pfizer | 101 to 250 | 2016 |
| DOT Compliance | DOT Compliance provides a ready-to-use cloud-based quality and compliance management solution for regulated industries. | Biotech | Ness Ziona, Israel | Series B | $17.5M | 2024-04-15 | Vertex Ventures, TPY Capital, Israel Growth Partners | 101 to 250 | 2007 | |
| Mistikist | Mistikist delivers personalized AI-driven mental wellbeing sessions for stress relief and focus in minutes. | Biotech | Mugla, Turkey | Seed | $161K | 2024-04-01 | $161K | Startup Wise Guys, European Innovation Council, Microsoft Accelerator +2 | 1 to 10 | 2024 |
| BioStaMix | BioStaMix is a biotechnology company that designs and manufactures nozzle tips for three-dimensional bioprinters. | Biotech | Çankaya, Turkey | Pre-seed | $30K | 2024-03-08 | Turkey Development Fund | 1 to 10 | 2023 | |
| EfA Technologies | EfA Technologies develops a programmable digital diagnostic lab-on-hand system. | Biotech | Caesarea, Israel | Seed | $6.5M | 2024-03-01 | eHealth Ventures | 1 to 10 | 2016 | |
| Aydinli Biotechnology | Aydinli Biotechnology researches and develops genetic breeding techniques to improve agricultural methods. | Biotech | Gebze, Turkey | Pre-seed | $30K | 2024-03-01 | Turkey Development Fund | 1 to 10 | 2023 | |
| WeedOut | WeedOut is a biotechnology company that provides weed control solutions. | Biotech | Ness Ziona, Israel | Series A | $8.1M | 2024-02-20 | Syngenta Ventures, Radicle Growth, Clay Capital +1 | 11 to 50 | 2016 | |
| Gozen Bioworks | Gozen Bioworks is a multidisciplinary materials science and design company. | Biotech | Istanbul, Turkey | Seed | $3.3M | 2023-10-25 | SOSV, SOSV SF & NY (Fka IndieBio), Happiness Capital +1 | 1 to 10 | 2020 | |
| Gina Life | Gina Life develops AI-supported biomarker platforms for early detection in women's health. | Biotech | Haifa, Israel | Seed | $3.1M | 2023-08-29 | $3.1M | MassChallenge, Pitango VC, MassChallenge Israel +2 | 1 to 10 | 2020 |
| Quris | Quris provides an AI platform that predicts which drug candidates will safely work in humans. | Artificial intelligence | Tel Aviv, Israel | Seed | $9.0M | 2022-12-20 | $37.0M | SoftBank Vision Fund, iAngels, Fusion +1 | 11 to 50 | 2019 |
| NeuroBrave | NeuroBrave provides access to real-time cognitive and emotional states through everyday wearable devices. | Artificial intelligence | Tel Aviv, Israel | Angel | $300K | 2022-08-19 | Intel Ignite, Samurai Incubate, Italian Angels for Growth +2 | 11 to 50 | 2020 | |
| Accellix | Accellix provides an assay delivery platform. | Biotech | Jerusalem, Israel | Series E | $10.0M | 2021-12-13 | BroadOak Capital Partners | 51 to 100 | 2013 | |
| MobileODT | MobileODT develops AI-based medical devices for cervical cancer screening. | Artificial intelligence | Tel Aviv, Israel | Series C | $4.0M | 2020-08-12 | MedTech Innovator, OrbiMed, VU Venture Partners +2 | 11 to 50 | 2012 | |
| BIO-NEXUS | BIO-NEXUS develops medical devices and systems. | Biotech | Netanya, Israel | Series A | $3.0M | 2016-08-23 | $3.0M | Springtide Ventures | 51 to 100 | 2010 |
| Nutrinia | Nutrinia develops therapies for patients with intestinal failure. | Biotech | Ramat Gan, Israel | Series D | $30.0M | 2016-08-18 | OrbiMed, Pontifax, WuXi Healthcare Ventures +2 | 11 to 50 | 2003 | |
| Origene Seeds | Origene Seeds breeds new vegetable varieties. | Biotech | Rehovot, Israel | Seed | $10.3M | 2015-10-29 | Fortissimo Capital | 11 to 50 | 2004 | |
| Quiet Therapeutics | Quiet Therapeutics is a biotech company developing a proprietary nanoparticle-based drug delivery system. | Biotech | Ness Ziona, Israel | Series A | $12.0M | 2015-04-12 | Jerusalem Global Ventures, Arkin Capital | 1 to 10 | 2009 | |
| Treato | Treato collects patient-written health experiences from blogs and forums to reveal patient opinions. | Artificial intelligence | Or Yehuda, Israel | Series B | $14.5M | 2013-04-23 | Western Technology Investment, OrbiMed, REV +1 | 11 to 50 | 2008 |
Table 1. Biotech startups in MENA: the 26 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 266.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Remepy | Remepy develops hybrid drugs that combine multiple therapeutic approaches for biotechnology research. | Artificial intelligence | Ramat Gan, Israel | Series A | $36.0M | 2026-08-12 | $51.0M | Samsung NEXT, NFX, Vine Ventures +2 | 11 to 50 | 2022 |
| 2 | Phytolon | Phytolon supplies natural food colors of high quality at low cost. | Biotech | Yoqne`am `illit, Israel | Series B | $23.6M | 2026-05-26 | $43.7M | MassChallenge, Trendlines Group, Millenium Food-Tech | 11 to 50 | 2018 |
| 3 | Scala Biodesign | Scala Biodesign provides partners with a computational solution that increases the value of proteins and speeds their development. | Artificial intelligence | Tel Aviv, Israel | Series A | $16.0M | 2026-03-31 | $26.2M | Intel Capital, Intel Ignite, TLV Partners | 1 to 10 | 2022 |
| 4 | M-Based | M-Based develops eco-friendly alternative materials made from mycelium, the root structure of mushrooms. | Biotech | Ankara, Turkey | Seed | $700K | 2026-10-01 | $700K | Hatcher+, Sente Ventures, Fark Labs | 1 to 10 | |
| 5 | Viseur AI | Viseur AI provides a medical imaging platform that helps hospitals and labs deploy digital pathology and radiology workflows. | Artificial intelligence | Ankara, Turkey | Seed | $350K | 2026-05-20 | $897K | Turkey Development Fund | 11 to 50 | 2024 |
Table 2. Biotech startups in MENA: the 5 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Turkey Development Fund | Fund of funds | Umraniye, Turkey | 12 | 5% | 1 | Viseur AI |
| 2 | MassChallenge | Startup accelerator | Boston, United States | 4 | 2% | 1 | Phytolon |
| 3 | OrbiMed | Private equity firm | New York, United States | 4 | 2% | ||
| 4 | OurCrowd | Venture capital firm | Jerusalem, Israel | 4 | 2% | ||
| 5 | Trendlines Group | Venture capital firm | Misgav, Israel | 3 | 1% | 1 | Phytolon |
| 6 | Pitango VC | Venture capital firm | Herzliya, Israel | 3 | 1% | ||
| 7 | Intel Ignite | Startup accelerator | Tel Aviv, Israel | 2 | 1% | 1 | Scala Biodesign |
| 8 | Hatcher+ | Micro VC fund | Singapore | 2 | 1% | 1 | M-Based |
| 9 | Sente Ventures | Corporate venture arm | Chicago, United States | 2 | 1% | 1 | M-Based |
| 10 | Ocean Azul Partners | Micro VC fund | Coral Gables, United States | 2 | 1% | ||
| 11 | European Innovation Council | Startup accelerator | Brussels, Belgium | 2 | 1% | ||
| 12 | ALIVE Israel HealthTech Fund | Venture capital firm | Tel Aviv, Israel | 2 | 1% | ||
| 13 | TÜBİTAK | Government investment office | Ankara, Turkey | 2 | 1% | ||
| 14 | Firstime Venture Capital | Venture capital firm | Tel Aviv, Israel | 1 | 0% | 1 | Remepy |
| 15 | NFX | Startup accelerator | San Francisco, United States | 1 | 0% | 1 | Remepy |
Table 3. Biotech startups in MENA: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 182 | 68% | $1.8B |
| Software | 52 | 20% | $289.2M |
| Artificial intelligence | 29 | 11% | $280.1M |
| Hardware | 17 | 6% | $64.0M |
| Education | 6 | 2% | $3.5M |
| Energy | 4 | 2% | |
| Cybersecurity | 3 | 1% | |
| Fintech | 2 | 1% | |
| Commerce | 1 | 0% |
Table 4. Biotech startups in MENA by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
Table 5. Biotech startups in MENA by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Countries
Table 6. Biotech startups in MENA by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.
Cities
Table 7. Biotech startups in MENA by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| October 2026 | 2 | 11% | $18.7M |
| September 2026 | 1 | 6% | |
| August 2026 | 2 | 11% | $36.5M |
| June 2026 | 2 | 11% | $150K |
| May 2026 | 4 | 22% | $33.5M |
| March 2026 | 3 | 17% | $18.1M |
| February 2026 | 1 | 6% | $18.0M |
| December 2025 | 3 | 17% | $23.0M |
Table 8. Biotech startups in MENA: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 15 | 6% | $125.0M |
| 2025 | 19 | 7% | $110.4M |
| 2024 | 40 | 15% | $185.1M |
| 2023 | 25 | 9% | $201.0M |
| 2022 | 32 | 12% | $373.3M |
| 2021 | 31 | 12% | $822.5M |
Table 9. Biotech startups in MENA by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 29 | 11% |
| 2020 to 2022 | 58 | 23% |
| 2015 to 2019 | 92 | 36% |
| 2010 to 2014 | 33 | 13% |
| Before 2010 | 45 | 18% |
Table 10. Biotech startups in MENA by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 134 | 53% |
| 11 to 50 | 94 | 37% |
| 51 to 100 | 13 | 5% |
| 101 to 250 | 12 | 5% |
| 501 to 1,000 | 1 | 0% |
Table 11. Biotech startups in MENA by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its headquarters is in MENA. On 16 November 2026 that is 266 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 26 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 266 rows: 68 have no round amount, 0 no city and 130 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in MENA are on the list?
- 266, in the file dated 16 November 2026. 18 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 266 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.